RediTrex™ (methotrexate) – New drug approval
December 2, 2019 - Cumberland Pharmaceuticals announced the FDA approval of RediTrex (methotrexate) injection, for the management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), and for symptomatic control of severe, recalcitrant, disabling psoriasis in adults.
Top